UK Stocks-Factors to watch on Jan. 28

Jan 28 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher on Friday with futures FFIc1 up 0.1%.

* CAPITA: British outsourcer Capita Plc CPI.L said it would sell its IT services and solutions business Trustmarque to private equity firm One Equity Partners for 111 million pounds on a cash-free, debt-free basis.

* AMIGO HOLDINGS: British subprime lender Amigo Holdings AMGO.L appointed Danny Malone as its interim chief financial officer, after the abrupt departure of finance chief Mike Corcoran earlier this week.

* INSURANCE: Britain's housing minister Michael Gove asked UK regulators to review the buildings insurance market to address "rapidly escalating" insurance premiums for flats and other multiple-occupancy buildings.

* TAX: Britain's planned increase in national insurance contributions from April 2022 will go ahead, Chris Philp, minister for technology and the digital economy, said.

* GLENCORE: Global commodities merchant Glencore Plc GLEN.L took a major step this week to becoming a greater force in the international food chain with a deal to buy the grains business of U.S.-based Gavilon.

* OIL: Oil prices rose, set for their sixth weekly gain, amid concerns of tight supplies as major producers continue their policy of limited output increases amid rising fuel demand.

* GOLD: Gold was flat and set for its sharpest weekly decline since November, as markets digested the U.S. Federal Reserve's policy tightening plans that propelled the dollar index to a multi-month peak.

* London's FTSE 100 rose on Thursday following strong results from spirits maker Diageo DGE.L and as bank stocks benefited from rising yields, while boots maker Dr. Martens DOCS.L dropped to a record low and pulled down British mid-caps.

* For more on the factors affecting European stocks, please click on:


> Financial Times

> Other business headlines

Reporting by Sinchita Mitra in Bengaluru

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.